PRDX6 and ovarian cancer: Taken together, these observations indicated that PRDX3, PRDX5, and PRDX6 overexpression could lead to the chemotherapy resistance in ovarian cancer and therapeutic strategies targeting these isoforms may therefore be an effective anticancer therapy for ovarian cancer.